Ross Moat sold $283K of Kiniksa Pharmaceuticals International (KNSA)

Executed May 2 2025, disclosed May 5 2025, 3 days later.

Value, as filed

$283K

10,122 sh across 2 lots

Executed

May 2 2025

the trade date, as filed

Disclosed

May 5 2025

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Ross Moat CHIEF OPERATING OFFICER profile →

Ross Moat (CHIEF OPERATING OFFICER) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Kiniksa Pharmaceuticals International, plc (KNSA). The largest single filing was $9.6M of KNSA (102,863 sh across 10 lots, as filed), executed Oct 30.

The name

KNSA

Kiniksa Pharmaceuticals International, plc KNSA · Healthcare · 72 filings in 24 months ticker →

Healthcare · Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Ross Moat in KNSA

KNSASALE Kiniksa Pharmaceuticals International, plc $9.6M
102,863 sh across 10 lots
Exec Oct 30
Filed Nov 3 · 6:27 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $115K
2,367 sh × $48.58
Exec Apr 6
Filed Apr 8 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $124K
3,523 sh × $35.31
Exec Sep 4 2025
Filed Sep 8 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $801K
27,594 sh × $29.02
Exec Jun 3 2025
Filed Jun 5 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $2.3M
87,269 sh across 2 lots
Exec Apr 29 2025
Filed May 1 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $370K
18,259 sh × $20.29
Exec Apr 21 2025
Filed Apr 23 2025 · 5:30 PM ET